Both interventions reduced weight, reversed obesity-induced alterations in insulin, leptin, and inflammatory factors, and decreased tumor incidence and mass, with intermittent energy restriction producing the most favorable antitumor immune and metabolic environment. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.